Literature DB >> 24370545

R1 hepatectomy with exposure of tumor surface for centrally located hepatocellular carcinoma.

Weibo Yu1, Weiqi Rong, Liming Wang, Fan Wu, Quan Xu, Jianxiong Wu.   

Abstract

BACKGROUND: Hepatectomy with exposure of tumor surface (a special type of R1 resection) provides a chance of cure for selected patients with centrally located hepatocellular carcinoma (HCC) that is adherent to or compresses major vessels. However, the operative indications, safety, and patient outcomes are not well defined.
METHODS: We performed hepatectomy for removal of complex centrally located HCC using a selective and dynamic region-specific vascular occlusion technique. Between May 2006 and March 2012, a total of 118 patients underwent resection with exposure of tumor surface (exposure group) and 169 underwent conventional hepatectomy (without exposure of the tumor and vascular surface). The short- and long-term outcomes of patients were evaluated and compared.
RESULTS: The postoperative recovery of liver function was comparable between the two groups. Bile leakage occurred in five patients, all in the exposure group. The 1-, 3-, and 5-year recurrence-free survival rates were 74.4, 45.6, and 30.1 % in the exposure group and 80.9, 57.2, and 31.7 % in the control group (p = 0.041). Corresponding overall survival rates were 92.3, 70.3, and 44.9 % in the exposure group and 97.8, 81.4, and 53.1 % in the control group (p = 0.094).
CONCLUSIONS: Hepatectomy with exposure of tumor surface is technically demanding, but can be performed safely. It is also associated with a risk of tumor recurrence. Multidisciplinary combined therapy would be the solution and can contribute to improve overall survival.

Entities:  

Mesh:

Year:  2014        PMID: 24370545     DOI: 10.1007/s00268-013-2429-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

1.  Mesohepatectomy.

Authors:  C H Scudamore; A K Buczkowski; H Shayan; S G Ho; G M Legiehn; S W Chung; D A Owen
Journal:  Am J Surg       Date:  2000-05       Impact factor: 2.565

2.  A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.

Authors:  Wei-Ping Zhou; Eric C H Lai; Ai-Jun Li; Si-Yuan Fu; Jian-Ping Zhou; Ze-Ya Pan; Wan Yee Lau; Meng-Chao Wu
Journal:  Ann Surg       Date:  2009-02       Impact factor: 12.969

3.  Safety of hemihepatic vascular occlusion during resection of the liver.

Authors:  M Makuuchi; T Mori; P Gunvén; S Yamazaki; H Hasegawa
Journal:  Surg Gynecol Obstet       Date:  1987-02

4.  Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial.

Authors:  Juan Figueras; Laura Llado; David Ruiz; Emilio Ramos; Juli Busquets; Antonio Rafecas; Jaume Torras; Juan Fabregat
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

5.  Treatment of centrally located hepatocellular carcinoma with central hepatectomy.

Authors:  Rey-Heng Hu; Po-Huang Lee; Yue-Cune Chang; Ming-Chih Ho; Sen-Chang Yu
Journal:  Surgery       Date:  2003-03       Impact factor: 3.982

6.  Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.

Authors:  Divya Dahiya; Ting-Jung Wu; Chen-Fang Lee; Kun-Ming Chan; Wei-Chen Lee; Miin-Fun Chen
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

7.  Complex hepatectomy under total vascular exclusion of the liver: impact of ischemic preconditioning on clinical outcomes.

Authors:  Jangyong Jeon; Anthony Watkins; Gebhard Wagener; Benjamin Samstein; James Guarrera; Michael Goldstein; Joseph Meltzer; Tomoaki Kato; Jean C Emond
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

8.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

9.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

10.  Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection.

Authors:  Yoichi Matsui; Naoyoshi Terakawa; Sohei Satoi; Masaki Kaibori; Hiroaki Kitade; Soichiro Takai; A-Hon Kwon; Yasuo Kamiyama
Journal:  Arch Surg       Date:  2007-07
View more
  7 in total

1.  Intensity-modulated radiotherapy following null-margin resection is associated with improved survival in the treatment of intrahepatic cholangiocarcinoma.

Authors:  Angela Y Jia; Jian-Xiong Wu; Yu-Ting Zhao; Ye-Xiong Li; Zhi Wang; Wei-Qi Rong; Li-Ming Wang; Jing Jin; Shu-Lian Wang; Yong-Wen Song; Yue-Ping Liu; Hua Ren; Hui Fang; Wen-Qing Wang; Xin-Fan Liu; Zi-Hao Yu; Wei-Hu Wang
Journal:  J Gastrointest Oncol       Date:  2015-04

2.  Adjuvant radiotherapy in central hepatocellular carcinoma after narrow-margin hepatectomy: A 10-year real-world evidence.

Authors:  Weiqi Rong; Weibo Yu; Liming Wang; Fan Wu; Kai Zhang; Bo Chen; Chengli Miao; Liguo Liu; Songlin An; Changcheng Tao; Weihu Wang; Jianxiong Wu
Journal:  Chin J Cancer Res       Date:  2020-10-31       Impact factor: 5.087

3.  Three-dimensional morphometric analysis for hepatectomy of centrally located hepatocellular carcinoma: a pilot study.

Authors:  Fei Tian; Jian-Xiong Wu; Wei-Qi Rong; Li-Ming Wang; Fan Wu; Wei-Bo Yu; Song-Lin An; Fa-Qiang Liu; Li Feng; Chao Bi; Yun-He Liu
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

4.  Prognostic Factors and Clinical Characteristics for Hepatocellular Carcinoma Patients with Benign Enlarged Perihepatic Lymph Nodes: a Single-Center Experience from China.

Authors:  Fei Tian; Jian-Xiong Wu; Wei-Bo Yu
Journal:  J Gastrointest Surg       Date:  2015-08-11       Impact factor: 3.452

5.  Mesohepatectomy Versus Extended Hemihepatectomies for Centrally Located Liver Tumors: A Meta-Analysis.

Authors:  Jianbo Li; Chengdi Wang; Jiulin Song; Nan Chen; Li Jiang; Jiayin Yang; Lunan Yan
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

Review 6.  Management of centrally located hepatocellular carcinoma: Update 2016.

Authors:  Wei-Bo Yu; Andrew Rao; Victor Vu; Lily Xu; Jian-Yu Rao; Jian-Xiong Wu
Journal:  World J Hepatol       Date:  2017-05-08

7.  The role of intraoperative electron radiotherapy in centrally located hepatocellular carcinomas treated with narrow-margin (<1 cm) hepatectomy: a prospective, phase 2 study.

Authors:  Liming Wang; Yunhe Liu; Weiqi Rong; Fan Wu; Weibo Yu; Kan Liu; Shengtao Lin; Yiling Zheng; Kai Zhang; Tana Siqin; Changcheng Tao; Mei Liu; Bo Chen; Qinfu Feng; Jianxiong Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.